Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Women (9)

Filter by Topic

Reproductive and maternal health (remove)
- Pregnancy (13)
Treatment (remove)
- HIV drugs (remove)
- Side effects (1)
Organ and body health (1)

Filter by Infection

HIV (remove)

Filter by Resource Category

Research summary (13)

Search results

Current filters: HIV, Treatment, Reproductive and maternal health, HIV drugs

13 search results

1
2

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women: 2018, CATIE
Research summary - Webpage
FDA warns that Prezcobix should not be used by HIV-positive pregnant women: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Decreasing the risk of neural tube defects with dolutegravir: From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

1
2

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.